(Q27341915)

English

Combination of liposomal CpG oligodeoxynucleotide 2006 and miltefosine induces strong cell-mediated immunity during experimental visceral leishmaniasis

scientific article (publication date: 2014)

In more languages

Statements

scholarly article

0 references

Combination of liposomal CpG oligodeoxynucleotide 2006 and miltefosine induces strong cell-mediated immunity during experimental visceral leishmaniasis (English)

0 references

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Rahul Shivahare

object named as

Rahul Shivahare

1

0 references

author name string

Preeti Vishwakarma

2

0 references

Naveen Parmar

3

0 references

Pawan Kumar Yadav

4

0 references

Wahajul Haq

5

0 references

Mrigank Srivastava

6

0 references

Suman Gupta

7

0 references

Susanta Kar

8

0 references

language of work or name

0 references

publication date

2014

0 references

0 references

9

0 references

4

0 references

e94596

0 references

copyright license

Creative Commons Attribution 4.0 International

14 April 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

21 March 2017

Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

21 March 2017

A Killing Disease Epidemic among Displaced Sudanese Population Identified as Visceral Leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

21 March 2017

Imipramine is an orally active drug against both antimony sensitive and resistant Leishmania donovani clinical isolates in experimental infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

21 March 2017

Leishmania donovani triose phosphate isomerase: a potential vaccine target against visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

21 March 2017

T-Cell Function and Migration — Two Sides of the Same Coin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

7 April 2017

Parasite burden in hamsters infected with two different strains of leishmania (Leishmania) infantum: "Leishman Donovan units" versus real-time PCR.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

29 September 2017

Structures, targets and recent approaches in anti-leishmanial drug discovery and development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

29 September 2017

Recent advances in leishmaniasis treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

29 September 2017

CpG oligodeoxynucleotide 2006 and miltefosine, a potential combination for treatment of experimental visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

29 September 2017

Immunological stimulation for the treatment of leishmaniasis: a modality worthy of serious consideration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

29 September 2017

Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

29 September 2017

New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

29 September 2017

Current scenario of drug development for leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

29 September 2017

Drug unresponsiveness & combination therapy for kala-azar

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

29 September 2017

Chemotherapy in the treatment and control of leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

29 September 2017

Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generati

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

29 September 2017

Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

29 September 2017

Immunopathogenesis of infection with the visceralizing Leishmania species

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

29 September 2017

Current trends in chemotherapy of tuberculosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

29 September 2017

Leishmaniasis: current situation and new perspectives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

29 September 2017

CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

29 September 2017

Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

29 September 2017

Gender is a major determinant of the clinical evolution and immune response in hamsters infected with Leishmania spp

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

29 September 2017

Detection of immunoglobulin G in the lung and liver of hamsters with visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

29 September 2017

Mechanism and function of a newly identified CpG DNA motif in human primary B cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

29 September 2017

Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

29 September 2017

Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

29 September 2017

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

29 September 2017

Invasion, control and persistence of Leishmania parasites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

29 September 2017

Mechanism and regulation of immunoglobulin isotype switching.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

29 September 2017

Lymphatic leishmaniasis in India

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

29 September 2017

Hormonal modulation of sex differences in resistance to Leishmania major systemic infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

29 September 2017

Comparison of T-cell responses in self-limiting versus progressive visceral Leishmania donovani infections in golden hamsters

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

29 September 2017

Combination therapy with paromomycin-associated stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

2 June 2018

Sex-determined resistance against Leishmania mexicana is associated with the preferential induction of a Th1-like response and IFN-gamma production by female but not male DBA/2 mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

2 June 2018

CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

2 June 2018

Sex differences and cross-immunity in DBA/2 mice infected with L. mexicana and L. major.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

2 June 2018

Seroepidemiological study on kala-azar in Baringo District, Kenya.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

2 June 2018

Sex-influenced population kinetics of Leishmania donovani in hamsters

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

2 June 2018

Morphology of the spleen and lymph nodes in fatal visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3986403

2 June 2018

Immunomodulatory effect of picroliv on the efficacy of paromomycin and miltefosine in combination in experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0094596

21 January 2018

Enhancement in therapeutic efficacy of miltefosine in combination with synthetic bacterial lipopeptide, Pam3Cys against experimental Visceral Leishmaniasis.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0094596

21 January 2018

Quassin alters the immunological patterns of murine macrophages through generation of nitric oxide to exert antileishmanial activity.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0094596

21 January 2018

Fucoidan cures infection with both antimony-susceptible and -resistant strains of Leishmania donovani through Th1 response and macrophage-derived oxidants.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0094596

21 January 2018

Successful therapy of visceral leishmaniasis with curdlan involves T-helper 17 cytokines

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0094596

21 January 2018

MAPK-directed phosphatases preferentially regulate pro- and anti-inflammatory cytokines in experimental visceral leishmaniasis: involvement of distinct protein kinase C isoforms.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0094596

21 January 2018

Treatment of Leishmania donovani-infected hamsters with miltefosine: analysis of cytokine mRNA expression by real-time PCR, lymphoproliferation, nitrite production and antibody responses.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0094596

21 January 2018

Mycobacterium indicus pranii (Mw)-mediated protection against visceral leishmaniasis: involvement of TLR4 signalling.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0094596

21 January 2018

Epidemiological patterns of canine leishmaniasis [correction of leishmaniosis] in Western Liguria (Italy).

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0094596

21 January 2018

HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0094596

21 January 2018

TGF-β-regulated tyrosine phosphatases induce lymphocyte apoptosis in Leishmania donovani-infected hamsters.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0094596

21 January 2018

Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0094596

21 January 2018

Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0094596

21 January 2018

Use of Leishmania donovani field isolates expressing the luciferase reporter gene in in vitro drug screening

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0094596

21 January 2018

Rationale of the multidrug regimens recommended by a World Health Organization Study Group on Chemotherapy of Leprosy for Control Programs

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sterically Stabilized Cationic Liposomes Improve the Uptake and Immunostimulatory Activity of CpG Oligonucleotides

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination of langur monkeys (Presbytis entellus) against Leishmania donovani with autoclaved L. major plus BCG

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serological investigations on Indian kala-azar

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Visceral leishmaniasis. Persistence of parasites in lymph nodes after clinical cure

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective inability of spleen antigen presenting cells from Leishmania donovani infected hamsters to mediate specific T cell proliferation to parasite antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leishmania major: in vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Miltefosine--the long-awaited therapy for visceral leishmaniasis?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0094596

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2014PLoSO...994596S

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27341915&oldid=1862074233"